<code id='810741480E'></code><style id='810741480E'></style>
    • <acronym id='810741480E'></acronym>
      <center id='810741480E'><center id='810741480E'><tfoot id='810741480E'></tfoot></center><abbr id='810741480E'><dir id='810741480E'><tfoot id='810741480E'></tfoot><noframes id='810741480E'>

    • <optgroup id='810741480E'><strike id='810741480E'><sup id='810741480E'></sup></strike><code id='810741480E'></code></optgroup>
        1. <b id='810741480E'><label id='810741480E'><select id='810741480E'><dt id='810741480E'><span id='810741480E'></span></dt></select></label></b><u id='810741480E'></u>
          <i id='810741480E'><strike id='810741480E'><tt id='810741480E'><pre id='810741480E'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:66
          Pregnancy and clinical trials
          Adobe

          The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

          Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

          advertisement

          Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          A Q&A with the global head of Boehringer Ingelheim's innovation unit
          A Q&A with the global head of Boehringer Ingelheim's innovation unit

          MichelPairetCourtesyBoehringerIngelheimLONDON—Ataneventherelastweek,theGermanpharmaceuticalfirmBoehr

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Alabama hospital puts IVF treatments on hold

          TheAlabamaSupremeCourtruledlastweekthatfrozenembryoscanbeconsideredchildrenunderstatelaw,andonWednes